These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7690000)

  • 1. The biological activities of trichosanthin after coupling to dextran.
    Ko WH; Yeung HW; Tam SC
    Gen Pharmacol; 1993 May; 24(3):757-62. PubMed ID: 7690000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of trichosanthin antigenicity by coupling to dextran.
    Ko WH; Wong CC; Yeung HW; Tam SC
    Biochem Int; 1992 Dec; 28(4):643-50. PubMed ID: 1282812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Position 120-123, a potential active site of trichosanthin.
    Nie H; Cai X; He X; Xu L; Ke X; Ke Y; Tam SC
    Life Sci; 1998; 62(6):491-500. PubMed ID: 9464461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minireview: trichosanthin--a protein with multiple pharmacological properties.
    Shaw PC; Chan WL; Yeung HW; Ng TB
    Life Sci; 1994; 55(4):253-62. PubMed ID: 8028444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of the Glu 160 and Glu 189 residues to the various biological activities of the ribosome inactivating protein trichosanthin.
    Ng TB; Shaw PC; Chan WY
    Life Sci; 1996 May; 58(26):2439-46. PubMed ID: 8691989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible mechanisms of trichosanthin-induced apoptosis of tumor cells.
    Li M; Li X; Li JC
    Anat Rec (Hoboken); 2010 Jun; 293(6):986-92. PubMed ID: 20225201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactive oxygen species involved in trichosanthin-induced apoptosis of human choriocarcinoma cells.
    Zhang C; Gong Y; Ma H; An C; Chen D; Chen ZL
    Biochem J; 2001 May; 355(Pt 3):653-61. PubMed ID: 11311127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lowering of trichosanthin immunogenicity by site-specific coupling to dextran.
    Chan WL; Shaw PC; Li XB; Xu QF; He XH; Tam SC
    Biochem Pharmacol; 1999 Apr; 57(8):927-34. PubMed ID: 10086327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-function relationship of trichosanthin.
    Ke YB; Chen JK; Nie HL; He XH; Ke XY; Wang YH
    Life Sci; 1997; 60(7):465-72. PubMed ID: 9042374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing the plasma half-life of trichosanthin by coupling to dextran.
    Ko WH; Wong CC; Yeung HW; Yung MH; Shaw PC; Tam SC
    Biochem Pharmacol; 1991 Oct; 42(9):1721-8. PubMed ID: 1718284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro immunotoxicity and cytotoxicity of trichosanthin against human normal immunocytes and leukemia-lymphoma cells.
    Zheng YT; Zhang WF; Ben KL; Wang JH
    Immunopharmacol Immunotoxicol; 1995 Feb; 17(1):69-79. PubMed ID: 7759776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High level synthesis of biologically active recombinant trichosanthin in Escherichia coli.
    Zhu RH; Ng TB; Yeung HW; Shaw PC
    Int J Pept Protein Res; 1992 Jan; 39(1):77-81. PubMed ID: 1634332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties of bromodextran-trichosanthin: a comparison with trichosanthin, an anti-AIDS protein.
    Yeung HW; Ng TB
    Biochem Int; 1991 Dec; 25(6):1051-9. PubMed ID: 1810249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunomodulatory and antitumor activities of trichosanthin-an abortifacient protein isolated from tian-hua-fen (Trichosanthes kirilowii).
    Leung KN; Yeung HW; Leung SO
    Asian Pac J Allergy Immunol; 1986 Dec; 4(2):111-20. PubMed ID: 3492210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trichosanthin induced calcium-dependent generation of reactive oxygen species in human choriocarcinoma cells.
    Zhang CY; Gong YX; Ma H; An CC; Chen DY
    Analyst; 2000 Sep; 125(9):1539-42. PubMed ID: 11064936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trichosanthin-induced autophagy in gastric cancer cell MKN-45 is dependent on reactive oxygen species (ROS) and NF-κB/p53 pathway.
    Wei B; Huang Q; Huang S; Mai W; Zhong X
    J Pharmacol Sci; 2016 Jun; 131(2):77-83. PubMed ID: 27032906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing the immunogenicity and improving the in vivo activity of trichosanthin by site-directed pegylation.
    He XH; Shaw PC; Tam SC
    Life Sci; 1999; 65(4):355-68. PubMed ID: 10421422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and Functional Investigation and Pharmacological Mechanism of Trichosanthin, a Type 1 Ribosome-Inactivating Protein.
    Shi WW; Wong KB; Shaw PC
    Toxins (Basel); 2018 Aug; 10(8):. PubMed ID: 30127254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on injury-mechanism of trichosanthin on trophoblast cells and choriocarcinoma cells in culture].
    Dai RX; Xu GJ; Lin XY; Liu LY; Shen HP; Zhou XG; Gao T; Wang YH
    Shi Yan Sheng Wu Xue Bao; 1993 Dec; 26(4):411-27. PubMed ID: 8023636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smac is another pathway in the anti-tumour activity of Trichosanthin and reverses Trichosanthin resistance in CaSki cervical cancer cells.
    Cui L; Song J; Wu L; Huang L; Wang Y; Huang Y; Yu H; Huang Y; You CC; Ye J
    Biomed Pharmacother; 2015 Feb; 69():119-24. PubMed ID: 25661347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.